We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scancell Holdings Plc | LSE:SCLP | London | Ordinary Share | GB00B63D3314 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 9.60 | 9.40 | 9.80 | 9.60 | 9.38 | 9.60 | 148,854 | 08:00:21 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.27M | -11.94M | -0.0129 | -7.44 | 89.07M |
Date | Subject | Author | Discuss |
---|---|---|---|
30/6/2017 16:21 | J7 A poorly paid clown is still a happy clown The Club are unhappy with an average of 46p. The astute never joined the club and as a result we are not drowning......enjoy the re-flotation before someone comes around and bursts your rubber rings. | terror | |
30/6/2017 15:14 | See you in October. | tosh123 | |
30/6/2017 14:57 | I do know.You are nothing but a clown a poorly paid clown. | j777j | |
30/6/2017 14:50 | J777J.... honestly, you really should be on the stage. As for knowing about business, if only you knew ! Meanwhile the share price is up 25% ???? Yes it is, Its up 25% from a 6 year low !!!! so the current share price is about 60% down from what it was about 2 years ago, and about 80% down from where it was about 4 years ago.... Not a great performance in anyone's book. You're an idiot and i wait to meet you back here in October complete with your £1 / share... hahaha | tosh123 | |
30/6/2017 14:47 | What kind of scum would use terror as a bb name?I suggest you read up the draconian UK anti terror laws.The promotion,distributi | j777j | |
30/6/2017 14:40 | J777J Terror = nothing to do with recent events but merely a football nickname. Suggest you tone down your posts or you will get as bad as the folks on here. LOL | terror | |
30/6/2017 14:33 | J777J OK, so lets meet back here in lets say, October, by which time , according to you, there would have been a trade sale at at least £1 / share. Im going to suggest that in October, far from having a trade sale at a price north of £1, that there will have been no sale, and that we will have had further dilution due to another fund raising event, and the share price will probably be back into single figures. | tosh123 | |
30/6/2017 14:29 | What kind of gutter scum comes on the boards with a name like terror? Utter scum. | j777j | |
30/6/2017 14:08 | Panmure Gordon Wed, 18th May 2016 - 12:30 Panmure Gordon today reaffirms its buy investment rating on Scancell Holdings PLC (LON:SCLP) and cut its price target to 68p (from 79p). 10p placing Panmure Gordon (UK) Limited ("Panmure Gordon") is acting as Financial Adviser, Nominated Adviser and sole Bookrunner to the Company in relation to the Placing. LOL PG=LIES | terror | |
30/6/2017 13:47 | j7 How many times have we heard all this before ? Mtb4 | mikethebike4 | |
30/6/2017 13:20 | Remember this just a few months ago....."Panmure Gordon analyst Mike Mitchell, in a note to clients, said Scancell is poised for a "significant" year."Immunotherapy as a field continues to generate ever-more-prominent headlines and we view Scancell as a seriously overlooked player in this area," he added." | j777j | |
30/6/2017 13:14 | You will note.all Chiplin's companies were either acquired IPO ed Scancell is next. | j777j | |
30/6/2017 13:11 | This has been the game.plan for a while and I suspect the global patent will now expedite the trade sale.They brought in a heavyweight US industry pro in order to break into the USA.Dr John Chiplin, who is based in the US and is currently Scancell's Non-Executive Chairman, will assume the role of Executive Chairman. John will be directly involved in raising the corporate profile of the Company in the US. Recent US transaction experience, as a director/CEO, includes Benitec Biopharma (US IPO), Medistem (acquired by Intrexon), Arana (acquired by Cephalon) and Domantis (acquired by GSK). Prior to Scancell John was CEO of Polynoma, a Phase III cancer vaccine company, based in San Diego. | j777j | |
30/6/2017 13:04 | Re 9755 What folks see here is Suntans's 'good side', overjoyed with the rise in S P, that has the effect of 'lifting' him from 'sitting on HUGE LOSSES'... to now, merely 'sitting on BIG LOSSES' With the FUNDING question STILL to be resolved. Don't see how ANYONE could be " disappointed ... but following recent good news the share price continues to rise." with that out-look. *WE* must hope the 'fun BUYers' are not being 'set-up' for a shock ??? | the real lozan | |
30/6/2017 13:01 | I expect this to have a trade sale within a few months.Without global patent protection there is little value.With global patent protection,this is a viable and valuable business.100p a share my takeover price target. | j777j | |
30/6/2017 12:51 | 10 bagger in two years - seems like a good return to me. | gazza | |
30/6/2017 12:46 | J777J.... Hahaha .. You should be on the stage ! havn't you forgotten a little something ? The matter of an insignificant £22 mill or so. You havn't been talking to that inbred ineptico have you ? This may well make £1 +, but you wont be seeing anything like that lofty figure for a couple of years yet. | tosh123 | |
30/6/2017 12:42 | I appreciate from some of the comments on here that people will be disappointed but following recent good news the share price continues to rise. | 888icb | |
30/6/2017 12:36 | Scum and paid derampers my oh my what a unpleasant little man you are. | wanderer1210_0 | |
30/6/2017 12:27 | With global patents now wrapped up expect the co to be sold.Won't get much change from 100p a shareSteady solid buying. | j777j | |
30/6/2017 10:57 | So - The question of the VITAL FUNDING does not appear to have been completely 'swept under the carpet' for those who prefer to keep an eye on the TRUE SITUATION ??? Quite refreshing No doubt folks have their own views on what they think - for the "FUNDING is not an issue" ISSUE is resolved, and WE see - what will be the 'final out-scum'. | the real lozan | |
30/6/2017 10:40 | We have seen this on two previous occassions. A modest rise, as institutions sell, followed by a placing at a much lower share price As the funds required are in percentage terms so much greater, what price the placing shares? | nextlink | |
30/6/2017 10:34 | I'm afraid all these sclp rises after news end the same way for us PIs mtb4 | mikethebike4 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions